# MPCi

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/mpci
Canonical HTML page: https://getbiobrief.com/entity/mpci

## Timeline

- **2026-08-10**: Series B financing closed — US$100 million Series B round closed, led by Granite Asia and a strategic investor, bringing total funding to nearly $200 million.
- **2023**: Company founded — Aureka Biotechnologies is founded as an AI-native TechBio company aiming to build biological world models.

## Recent coverage (1 stories)

### Aureka Biotech Raises $100M Series B for Biological Foundation Models
2026-08-11 04:20:53 · Sentiment: Positive · Impact: 7/10 · Sources: 2

Aureka Biotechnologies closed a $100 million Series B to build a closed-loop AI infrastructure that integrates foundation models with high-throughput experiments. The funding aims to advance de novo molecular design and biological structure prediction, marking a shift from AI-as-tool to AI-as-platform in biopharma R&D.
Full story: https://getbiobrief.com/story/aureka-biotech-100m-series-b-biological-foundation-models

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.